| Quarter | Score |
|---|---|
| 2022-Q2 | 56.4 |
| 2022-Q3 | 55.2 |
| 2022-Q4 | 37.1 |
| 2023-Q2 | 58.0 |
| 2023-Q3 | 48.7 |
| 2023-Q4 | 42.5 |
| 2024-Q1 | 53.6 |
| 2024-Q2 | 50.0 |
| 2024-Q3 | 76.5 |
| 2024-Q4 | 75.1 |
| 2025-Q1 | 74.9 |
| 2025-Q2 | 76.0 |
| 2025-Q3 | 76.6 |
| 2025-Q4 | 77.1 |
| 2026-Q1 | 76.7 |
| 2026-Q2 | 76.6 |
High consensus with active accumulation at an attractive valuation
Within 4.0% of funds' estimated purchase price
4 of 18 tracked funds hold BLCO. Avg conviction: 0.4%. Net adding. First tracked at $16.54 (current +4.0% vs tracked).
Oaktree Capital has 0.8% in this stock
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 17 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|---|---|
| Oaktree Capital | 0.8% | Add |
| Icahn Capital | 0.7% | Hold |
| Third Point | 0.0% | New Buy |
| Citadel Advisors | 0.0% |
| Add |